Bretylium tosylate

CAS No. 61-75-6

Bretylium tosylate( —— )

Catalog No. M20751 CAS No. 61-75-6

Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 62 In Stock
2MG 35 In Stock
5MG 56 In Stock
10MG 86 In Stock
25MG 113 In Stock
50MG 140 In Stock
100MG 166 In Stock
200MG 257 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bretylium tosylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.
  • Description
    Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others
  • Indication
    xerophthalmia

Chemical Information

  • CAS Number
    61-75-6
  • Formula Weight
    414.36
  • Molecular Formula
    C18H24BrNO3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (72.40 mM)
  • SMILES
    CC1=CC=C(C=C1)S([O-])(=O)=O.CC[N+](C)(C)CC1=CC=CC=C1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dhurandhar R W Teasdale S J Mahon W A . Bretylium Tosylate in the Management of Refractory Ventricular Fibrillation[J]. Canadian Medical Association journal 1971 105(2):161-5 passim.
molnova catalog
related products
  • AK-778-XXMU

    AK-778-XXMU is an ID2 antagonist with a KD value of 129 nM.AK-778-XXMU has potential antitumor and anticancer activity and can be used for the study of gliomas.

  • TriacetonaMine

    Triacetonamine protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles.

  • COH34 analog 1

    COH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.